AEE Quote, Financials, Valuation and Earnings

Entergy has a net margin of 10.67% compared to Ameren's net margin of 10.47%. Ameren's return on equity of 10.03% beat Entergy's return on equity of 7.14%.

Ameren has a consensus price target of $101.07, signalling upside risk potential of 2.48%. On the other hand Entergy has an analysts' consensus of $89.23 which suggests that it could grow by 5.9%. Given that Entergy has higher upside potential than Ameren, analysts believe Entergy is more attractive than Ameren.

Ameren has a beta of 0.454, which suggesting that the stock is 54.589% less volatile than S&P 500. In comparison Entergy has a beta of 0.560, suggesting its less volatile than the S&P 500 by 43.975%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.76%. Entergy offers a yield of 2.77% to investors and pays a quarterly dividend of $0.60 per share. Ameren pays 60.41% of its earnings as a dividend. Entergy pays out 94.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $1.9B, which are smaller than Entergy quarterly revenues of $2.7B. Ameren's net income of $207M is lower than Entergy's net income of $287.2M. Notably, Ameren's price-to-earnings ratio is 22.31x while Entergy's PE ratio is 34.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.46x versus 3.06x for Entergy. Usually stocks with elevated PS ratios are considered overvalued.

Exelon has a net margin of 10.67% compared to Ameren's net margin of 11.83%. Ameren's return on equity of 10.03% beat Exelon's return on equity of 9.35%.

Ameren has a consensus price target of $101.07, signalling upside risk potential of 2.48%. On the other hand Exelon has an analysts' consensus of $46.03 which suggests that it could fall by -1.64%. Given that Ameren has higher upside potential than Exelon, analysts believe Ameren is more attractive than Exelon.

Ameren has a beta of 0.454, which suggesting that the stock is 54.589% less volatile than S&P 500. In comparison Exelon has a beta of 0.393, suggesting its less volatile than the S&P 500 by 60.692%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.76%. Exelon offers a yield of 3.29% to investors and pays a quarterly dividend of $0.40 per share. Ameren pays 60.41% of its earnings as a dividend. Exelon pays out 61.95% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $1.9B, which are smaller than Exelon quarterly revenues of $5.5B. Ameren's net income of $207M is lower than Exelon's net income of $647M. Notably, Ameren's price-to-earnings ratio is 22.31x while Exelon's PE ratio is 19.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.46x versus 2.04x for Exelon. Usually stocks with elevated PS ratios are considered overvalued.

NiSource has a net margin of 10.67% compared to Ameren's net margin of 14.1%. Ameren's return on equity of 10.03% beat NiSource's return on equity of 7.49%.

Ameren has a consensus price target of $101.07, signalling upside risk potential of 2.48%. On the other hand NiSource has an analysts' consensus of $41.90 which suggests that it could grow by 6.56%. Given that NiSource has higher upside potential than Ameren, analysts believe NiSource is more attractive than Ameren.

Ameren has a beta of 0.454, which suggesting that the stock is 54.589% less volatile than S&P 500. In comparison NiSource has a beta of 0.483, suggesting its less volatile than the S&P 500 by 51.669%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.76%. NiSource offers a yield of 2.73% to investors and pays a quarterly dividend of $0.28 per share. Ameren pays 60.41% of its earnings as a dividend. NiSource pays out 64.34% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $1.9B, which are larger than NiSource quarterly revenues of $1.6B. Ameren's net income of $207M is lower than NiSource's net income of $223.9M. Notably, Ameren's price-to-earnings ratio is 22.31x while NiSource's PE ratio is 24.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.46x versus 3.29x for NiSource. Usually stocks with elevated PS ratios are considered overvalued.

Vistra has a net margin of 10.67% compared to Ameren's net margin of 10.92%. Ameren's return on equity of 10.03% beat Vistra's return on equity of 38.93%.

Ameren has a consensus price target of $101.07, signalling upside risk potential of 2.48%. On the other hand Vistra has an analysts' consensus of $165.44 which suggests that it could grow by 37.87%. Given that Vistra has higher upside potential than Ameren, analysts believe Vistra is more attractive than Ameren.

Ameren has a beta of 0.454, which suggesting that the stock is 54.589% less volatile than S&P 500. In comparison Vistra has a beta of 1.216, suggesting its more volatile than the S&P 500 by 21.619%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.76%. Vistra offers a yield of 0.74% to investors and pays a quarterly dividend of $0.22 per share. Ameren pays 60.41% of its earnings as a dividend. Vistra pays out 17.98% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $1.9B, which are smaller than Vistra quarterly revenues of $4B. Ameren's net income of $207M is lower than Vistra's net income of $441M. Notably, Ameren's price-to-earnings ratio is 22.31x while Vistra's PE ratio is 17.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.46x versus 2.44x for Vistra. Usually stocks with elevated PS ratios are considered overvalued.